New drug combo shows promise in advanced melanoma trial
NCT ID NCT04109456
First seen Jan 17, 2026 · Last updated May 14, 2026 · Updated 18 times
Summary
This early-stage trial tested the safety of a new drug called IN10018, given alone or with other medicines, in 51 adults with advanced melanoma that had spread. The goal was to see if the treatment was safe and tolerable, not to cure the disease. Participants had either uveal melanoma or a specific genetic type of skin melanoma.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University Medical Center
New York, New York, 10032, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Linear Clinical Research
Nedlands, Western Australia, Australia
-
MD Anderson
Houston, Texas, 77030, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
St Vincent Hospital Sydney
Sydney, New South Wales, Australia
-
Sylvester Comprehensive Cancer Center.
Miami, Florida, 33136, United States
-
The Alfred Hospital
Melbourne, Victoria, Australia
Conditions
Explore the condition pages connected to this study.